Abstract:Alzheimer's disease (AD) is the most common form of dementia, and the molecular mechanisms that underlie AD pathophysiology remain unclear. AMP-activated protein kinase (AMPK) is a Ser/Thr kinase that functions as a central energy sensor to maintain cellular energy homeostasis. Furthermore, AMPK integrates several signaling pathways controlling de novo protein synthesis (mRNA translation) which is vital for long-term synaptic plasticity and memory formation. Dysregulation of energy homeostasis and de novo protein synthesis are both implicated in AD. AMPK is a heterotrimeric protein with a catalytic α subunit and regulatory β/γ subunit. The α subunit of AMPK exists in two isoforms: α1 and α2, and their roles in AD are unknown. Post Mortem brain tissue from human AD was examined by both western blot and immunohistochemistry for AMPKα1 and AMPKα2 levels. AMPKα1 protein levels were selectively reduced in late development in the forebrain of Tg19959 AD model mice to generate AMPKα1(+/-)/Tg19959 double mutant mice. These mice were cognitively assessed by Morris Water Maze (MWM) and Novel Object Recognition (NOR) tasks. Hippocampal long-term potentiation (LTP) was measured to assess synaptic plasticity, moreover dendritic spine morphology was examined by Golgi Stain. In human hippocampal tissue AMPKα1 levels were dramatically increased, while levels of AMPKα2 were decreased in comparison with age-matched controls. These changes were neuronally localized and AD hippocampi specific. AD associated impairments of cognition and synaptic plasticity were alleviated in AMPKα1(+/-)/Tg19959 double mutant mice. Analysis of dendritic spine morphology revealed the hippocampal abnormalities in theTg19959 model mice were restored with genetic reduction of AMPKα1. AMPKα1 is abnormally neuronally upregulated in AD. Our results demonstrate that restoration of AMPKα1 levels in an AD model mouse ameliorates the behavioral and synaptic plasticity impairments. Our findings indicate AMPKα1 dysregulation as a molecular mechanism underlying AD pathophysiology, and providing insights into a potential therapeutic strategy.

Suppression of Hippocampal GABAergic Transmission Impairs Memory in Rodent Models of Alzheimer's Disease.

Long-Term Potentiation is Impaired in Middle-Aged Rats: Regional Specificity and Reversal by Adenosine Receptor Antagonists

Epigenetic Suppression of Hippocampal BDNF Mediates the Memory Deficiency Induced by Amyloid Fibrils

Brain-derived Neurotrophic Factor Ameliorates Learning Deficits in a Rat Model of Alzheimer's Disease Induced by Aβ1-42.

Role of GABA B receptors in cognition and EEG activity in aged APP and PS1 transgenic mice

Retracted: 1h-Mrs Can Monitor Metabolites Changes Of Lateral Intraventricular Bdnf Infusion Into A Mouse Model Of Alzheimer'S Disease In Vivo(Retracted Article. See Vol. 254, Pg. 477, 2013)

Retracted: 1H-MRS Can Monitor Metabolites Changes of Lateral Intraventricular BDNF Infusion into a Mouse Model of Alzheimer’s Disease in Vivo [neuroscience 245 (2013) 40–49]

1H-MRS can monitor metabolites changes of lateral intraventricular BDNF infusion into a mouse model of Alzheimer's disease in vivo.

Dysregulated CRTC1-BDNF signaling pathway in the hippocampus contributes to Aβ oligomer-induced long-term synaptic plasticity and memory impairment

GABA attenuates amyloid toxicity by downregulating its endocytosis and improves cognitive impairment.

Requirements of Postnatal proBDNF in the Hippocampus for Spatial Memory Consolidation and Neural Function

Increased GHS-R1a expression in the hippocampus impairs memory encoding and contributes to AD-associated memory deficits

CTBP1 Confers Protection for Hippocampal and Cortical Neurons in Rat Models of Alzheimer’s Disease

Reversible GABAergic dysfunction involved in hippocampal hyperactivity predicts early-stage Alzheimer disease in a mouse model

BACE1 in PV interneuron tunes hippocampal CA1 local circuits and resets priming of fear memory extinction

Enhancement of nose-to-brain delivery of basic fibroblast growth factor for improving rat memory impairments induced by co-injection of β-amyloid and ibotenic acid into the bilateral hippocampus.

P2‐157: BRAIN‐SPECIFIC REPRESSION OF AMPKα1 ALLEVIATES MEMORY DEFICITS AND SYNAPTIC FAILURE IN A MOUSE MODEL OF ALZHEIMER'S DISEASE

Dysregulating mTORC1-4E-BP2 signaling in GABAergic interneurons impairs hippocampus-dependent learning and memory

Maternal immune activation-induced proBDNF-mediated neural information processing dysfunction at hippocampal CA3-CA1 synapses associated with memory deficits in offspring

Impairments of GABAergic Transmission in Hippocampus Mediate Increased Susceptibility of Epilepsy in the Early Stage of Alzheimer’s Disease

Alzheimer’s Disease Enhanced Tonic Inhibition is Correlated With Upregulated Astrocyte GABA Transporter-3/4 in a Knock-In APP Mouse Model